Global Geographic Trends in Antimicrobial Resistance: The Role of International Travel.
Venue: Journal of travel medicine
Year: 2019

Rising antimicrobial resistance (AMR) is a threat to modern medicine and increasing international mobility facilitates the spread of AMR. Infections with resistant organisms have higher morbidity and mortality, are costlier to treat, result in longer hospital stays, and place a greater burden on health systems than infections caused by susceptible organisms. Here we review the role of travel in the international dissemination of antimicrobial resistance and consider actions at the levels of travelers, travel medicine practitioners, and policymakers that would mitigate this threat.  Resistant pathogens do not recognize international borders; travelers to areas with high AMR prevalence are likely to be exposed to resistant bacteria and return to their home countries colonized. Medical tourists go between health facilities with drastically different rates of AMR, potentially transmitting highly resistant strains.Drug resistant bacteria have been found in every continent, however, differences between countries in the prevalence of AMR depend on multiple factors. These include levels of antibiotic consumption (including inappropriate use) access to clean water, adequate sanitation, vaccination coverage, the availability of quality healthcare, and access to high quality medical products.  Travelers to areas with high levels of AMR should have vaccines up to date, be aware of ways of treating and preventing travelers' diarrhea (other than antibiotic use) and be informed on safe sexual practices. The healthcare systems of low and middle income countries require investment to reduce the transmission of resistant strains by improving access to clean water, sanitation facilities and vaccines. Efforts are needed to curb inappropriate antibiotic use worldwide. In addition, more surveillance is needed to understand the role of the movement of humans, livestock and food products in resistance transmission. The travel medicine community has a key role to play in advocating for the recognition of AMR as a priority on the international health agenda. KEY POLICY RECOMMENDATIONS Antimicrobial resistance is a threat to modern medicine and international travel plays a key role in the spread of highly resistant strains. It is essential that this is addressed at multiple levels: Individual travelers can reduce antibiotic consumption and the likelihood of infection. Travelers should have up to date vaccines and be informed on methods of preventing and treating travelers' diarrhea, other than use of antibiotics, and on safe sexual practices, such as condom use. Healthcare facilities need to be aware of the travel history of patients to provide appropriate treatment to those who are at high risk of exposure and to prevent further spread. Internationally, in countries without reliable and universal access to clean water, sanitation and hygiene, investment is needed to reduce the emergence and spread of resistance and ensure the antimicrobials available are of assured quality. High income countries must ensure their use of antimicrobials is appropriate to reduce selection for AMR. Surveillance across all countries is needed to monitor and respond to this emerging threat.